Satellos Bioscience Inc. Common Stock (MSLE) — Long-term Investment Intensity
Satellos Bioscience Inc. Common Stock (MSLE) has a Long-term Investment Intensity of 0.1% as of December 2023. Long-term investments of $30.91K represent 0.1% of total assets of $44.30 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check MSLE financial resilience to evaluate the company's liquid asset resilience ratio.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Satellos Bioscience Inc. Common Stock Long-term Investment Intensity (2022–2023)
This chart shows how Satellos Bioscience Inc. Common Stock's Long-term Investment Intensity has evolved across 2 annual periods from 2022 to 2023. As of December 2023, the intensity stands at 0.1%, reflecting long-term investments of $30.91K against total assets of $44.30 Million USD. For the complete balance sheet picture, see Satellos Bioscience Inc. Common Stock assets under control.
Annual Long-term Investment Intensity for Satellos Bioscience Inc. Common Stock (2022–2023)
The table below presents the year-by-year Long-term Investment Intensity for Satellos Bioscience Inc. Common Stock from 2022 to 2023, covering 2 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read MSLE liabilities breakdown for a breakdown of total debt and financial obligations.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2023 | 0.1% | $30.91K | $44.30 Million | ▼ -0.4 pp |
| 2022 | 0.5% | $30.95K | $6.14 Million | — |